Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis

Pfizer

Status: Completed

Conditions: Psoriasis; Arthritis, Psoriatic

Treatments: Other: questionnaire

Study type: Observational

Funder types: Industry

Identifiers

NCT00998829

0881A6-4611

B1801063

Details and patient eligibility

About

This study aims to collect Australian data on the prevalence of undiagnosed psoriatic arthritis in patients with plaque psoriasis. In addition the study will assess disease severity and quality of life in Australian patients with psoriasis attending specialist dermatology clinics.

Full description

Consecutive psoriasis patients seen at each site will be invited to participate in the study

Enrollment: 458 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of plaque psoriasis
• >= 18 years of age
• Able to complete English-language questionnaires

Exclusion criteria

• Participation in an interventional clinical trial in previous 3 months
• Known rheumatologist-confirmed psoriatic arthritis

Trial design

458 participants in 1 patient group

Study population

Description:

The group comprises the entire study population

Treatment:

Other: questionnaire